Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-13

Clinical Trial Update: GnRH Agonist Plus Hormone Replacement Therapy vs Hormone Replacement Therapy on IVF Outcomes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing GnRH agonist plus hormone replacement therapy versus hormone replacement therapy alone on IVF outcomes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GnRH agonist (gonadotropin-releasing hormone agonist)
  • Hormone Replacement Therapy

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Polycystic Ovary Syndrome, Infertility, Female | Phase 3 | Status: COMPLETED